PharmiWeb.com - Global Pharma News & Resources

Fate Therapeutics

Pharmaco

Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells.